JP2001514875A - 単離オステオカルシンフラグメント - Google Patents

単離オステオカルシンフラグメント

Info

Publication number
JP2001514875A
JP2001514875A JP2000509736A JP2000509736A JP2001514875A JP 2001514875 A JP2001514875 A JP 2001514875A JP 2000509736 A JP2000509736 A JP 2000509736A JP 2000509736 A JP2000509736 A JP 2000509736A JP 2001514875 A JP2001514875 A JP 2001514875A
Authority
JP
Japan
Prior art keywords
fragment
amino acid
hoc
osteocalcin
immunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000509736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001514875A5 (enExample
Inventor
ヘルマン，ユッカ
カーコーネン，サンナ−マリア
カルプ，マティ
レブグレン，ティモ
バーナネン，ホー．カレルボ
ペテルソン，キム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2001514875A publication Critical patent/JP2001514875A/ja
Publication of JP2001514875A5 publication Critical patent/JP2001514875A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2000509736A 1997-08-15 1998-06-24 単離オステオカルシンフラグメント Pending JP2001514875A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI973371A FI973371A0 (fi) 1997-08-15 1997-08-15 Nya isolerade peptider
FI973371 1997-08-15
PCT/FI1998/000550 WO1999009058A1 (en) 1997-08-15 1998-06-24 Isolated osteocalcin fragments

Publications (2)

Publication Number Publication Date
JP2001514875A true JP2001514875A (ja) 2001-09-18
JP2001514875A5 JP2001514875A5 (enExample) 2005-12-22

Family

ID=8549365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000509736A Pending JP2001514875A (ja) 1997-08-15 1998-06-24 単離オステオカルシンフラグメント

Country Status (4)

Country Link
EP (1) EP1003778A1 (enExample)
JP (1) JP2001514875A (enExample)
FI (1) FI973371A0 (enExample)
WO (1) WO1999009058A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI990693A0 (fi) 1999-03-29 1999-03-29 Kaekoenen Sanna Maria Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla
US7303884B1 (en) 1999-08-14 2007-12-04 november Aktiengesellschaft Gesellschaft für Molekulare Medizin Method for indirectly determining the blood-clotting status
SE0000675D0 (sv) * 2000-03-02 2000-03-02 Protease Ab Monoclonal antibodies
GB0107393D0 (en) * 2001-03-23 2001-05-16 Osteometer Biotech As A method of assaying osteocalcin fragments in body fluids a test kit and means for carrying out the method and use of the method to monitor bone resorption
US20220175888A1 (en) * 2018-04-30 2022-06-09 National Institute Of Immunology Carboxylated osteocalcin for treatment of amyloidosis or diseases associated with abnormal protein folding

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0557663B1 (en) * 1992-02-27 1997-05-02 Delmas, Pierre, Dr. Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin
JP3894381B2 (ja) * 1996-04-10 2007-03-22 株式会社ペプチド研究所 抗Ｇｌｕ▲１７▼−オステオカルシン抗体

Also Published As

Publication number Publication date
WO1999009058A1 (en) 1999-02-25
EP1003778A1 (en) 2000-05-31
FI973371A0 (fi) 1997-08-15

Similar Documents

Publication Publication Date Title
AU758562B2 (en) Method of identifying N-terminal proBNP
CA2522747C (en) Method of detecting native probnp with a monoclonal antibody binding to the amino acids 38-43
US7670805B2 (en) Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
EP1365022A1 (en) Adiponectin-associated protein
EP1455821B1 (en) Parathyroid hormone antibodies and related methods
CN100430727C (zh) 测定体液中的蛋白片段
Ivaska et al. Identification of novel proteolytic forms of osteocalcin in human urine
Teisner et al. Fetal antigen 2: an amniotic protein identified as the aminopropeptide of the α1 chain of human procollagen type I
JP2001514875A (ja) 単離オステオカルシンフラグメント
US6746847B1 (en) Diagnostic assay for human matrix Gla-protein and its use as a biomarker
Muller et al. Localization of two antigenic determinants in histone H4
US20040259167A1 (en) Isolated osteocalcin fragments
JPH04252954A (ja) タンパクの測定方法、試薬及びキット
JPH04252956A (ja) タンパク質の測定方法、試薬及びキット
JPH04252955A (ja) 蛋白質の測定方法、試薬及びキット
JPH09329600A (ja) 抗Ｇｌｕ▲１７▼−オステオカルシン抗体
KR100460292B1 (ko) 체액중의단백질파편검정
Kakonen Identification of novel proteolytic forms of osteocalcin in human urine
MXPA01007637A (en) METHOD OF IDENTIFYING N-TERMINAL proBNP

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050408

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080318

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080819